SCOPUS 정보 검색 플랫폼

Volumn 113, Issue 6, 2014, Pages 871-877

Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis

(4) Carthon, Bradley C a,b Ng, Chaan S a Pettaway, Curtis A a Pagliaro, Lance C a

a UNIVERSITY OF TEXAS (United States)

b EMORY UNIVERSITY (United States)

Author keywords

anti epidermal growth factor monoclonal antibody; penile neoplasms; squamous cell carcinoma; survival

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB;

ADOLESCENT; ADVANCED CANCER; AGED; ARTICLE; BLEEDING; BONE METASTASIS; BRONCHOSPASM; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RESISTANCE; CANCER SURVIVAL; CELLULITIS; CLINICAL ARTICLE; DRUG SAFETY; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PENIS CARCINOMA; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SCROTAL SQUAMOUS CELL CARCINOMA; SCROTUM DISORDER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; VISCERAL METASTASIS;

ANTI-EPIDERMAL GROWTH FACTOR MONOCLONAL ANTIBODY; PENILE NEOPLASMS; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; GENITAL NEOPLASMS, MALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PENILE NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SCROTUM;

EID: 84891915793 PISSN: 14644096 EISSN: 1464410X Source Type: Journal
DOI: 10.1111/bju.12450 Document Type: Article

Times cited : (87)

References (16)

1
- 1642341909
- Penile carcinoma: A challenge for the developing world
- Misra S, Chaturvedi A, Misra NC,. Penile carcinoma: a challenge for the developing world. Lancet Oncol 2004; 5: 240-247
- (2004) Lancet Oncol , vol.5 , pp. 240-247
- Misra, S.¹ Chaturvedi, A.² Misra, N.C.³

2
- 0027498014
- Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes
- Horenblas S, van Tinteren H, Delemarre JF, Moonen LM, Lustig V, van Waardenburg EW,. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol 1993; 149: 492-497
- (1993) J Urol , vol.149 , pp. 492-497
- Horenblas, S.¹ Van Tinteren, H.² Delemarre, J.F.³ Moonen, L.M.⁴ Lustig, V.⁵ Van Waardenburg, E.W.⁶

3
- 63649131389
- Multimodality therapy in penile cancer: When and which treatments?
- Pagliaro LC, Crook J,. Multimodality therapy in penile cancer: when and which treatments? World J Urol 2009; 27: 221-225
- (2009) World J Urol , vol.27 , pp. 221-225
- Pagliaro, L.C.¹ Crook, J.²

4
- 63649091663
- Penile cancer: Incremental insights into etiology, diagnosis, staging, and management
- Pettaway CA, Horenblas S,. Penile cancer: incremental insights into etiology, diagnosis, staging, and management. World J Urol 2009; 27: 139-140
- (2009) World J Urol , vol.27 , pp. 139-140
- Pettaway, C.A.¹ Horenblas, S.²

5
- 32544458810
- Prognostic factors in node-positive carcinoma of the penis
- Pandey D, Mahajan V, Kannan RR,. Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol 2006; 93: 133-138
- (2006) J Surg Oncol , vol.93 , pp. 133-138
- Pandey, D.¹ Mahajan, V.² Kannan, R.R.³

6
- 46249098611
- A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)
- for the EORTC Genito-Urinary Tract Cancer Group
- Theodore C, Skoneczna I, Bodrogi I, et=al.; for the EORTC Genito-Urinary Tract Cancer Group. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 2008; 19: 1304-1307
- (2008) Ann Oncol , vol.19 , pp. 1304-1307
- Theodore, C.¹ Skoneczna, I.² Bodrogi, I.³

7
- 77956233851
- Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: A phase II study
- Pagliaro LC, Williams DL, Daliani D, et=al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 2010; 28: 3851-3857
- (2010) J Clin Oncol , vol.28 , pp. 3851-3857
- Pagliaro, L.C.¹ Williams, D.L.² Daliani, D.³

8
- 33947270347
- Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma
- Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA,. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 2007; 177: 1335-1338
- (2007) J Urol , vol.177 , pp. 1335-1338
- Bermejo, C.¹ Busby, J.E.² Spiess, P.E.³ Heller, L.⁴ Pagliaro, L.C.⁵ Pettaway, C.A.⁶

9
- 74249096161
- Characterization of the EGF receptor status in penile cancer: Retrospective analysis of the course of the disease in 45 patients
- [In German]
- Börgermann C, Schmitz KJ, Sommer S, Rübben H, Krege S,. Characterization of the EGF receptor status in penile cancer: retrospective analysis of the course of the disease in 45 patients. Urologe A 2009; 48: 1483-1489 [In German]
- (2009) Urologe A , vol.48 , pp. 1483-1489
- Börgermann, C.¹ Schmitz, K.J.² Sommer, S.³ Rübben, H.⁴ Krege, S.⁵

10
- 75849134466
- EGFR overexpression in squamous cell carcinoma of the penis
- Lavens N, Gupta R, Wood LA,. EGFR overexpression in squamous cell carcinoma of the penis. Curr Oncol 2010; 17: 4-6
- (2010) Curr Oncol , vol.17 , pp. 4-6
- Lavens, N.¹ Gupta, R.² Wood, L.A.³

11
- 80051633427
- Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis
- Necchi A, Nicolai A, Colecchia M, et=al. Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol 2011; 29: e650-652
- (2011) J Clin Oncol , vol.29
- Necchi, A.¹ Nicolai, A.² Colecchia, M.³

12
- 0032826430
- Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: A Southwest Oncology Group study
- Haas GP, Blumenstein BA, Gagliano RG, et=al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999; 161: 1823-1825
- (1999) J Urol , vol.161 , pp. 1823-1825
- Haas, G.P.¹ Blumenstein, B.A.² Gagliano, R.G.³

13
- 80052748563
- Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin
- Maubec E, Petrow P, Scheer-Senyarich I, et=al. Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol 2011; 29: 3419-3426
- (2011) J Clin Oncol , vol.29 , pp. 3419-3426
- Maubec, E.¹ Petrow, P.² Scheer-Senyarich, I.³

14
- 84859782849
- The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas
- Chaux A, Cubilla AL,. The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas. Semin Diagn Pathol 2012; 29: 67-71
- (2012) Semin Diagn Pathol , vol.29 , pp. 67-71
- Chaux, A.¹ Cubilla, A.L.²

15
- 84876208927
- EGFR mutational status in penile cancer
- Di Lorenzo G, Buonerba C, Gaudioso G, et=al. EGFR mutational status in penile cancer. Expert Opin Ther Targets 2013; 17: 501-505
- (2013) Expert Opin Ther Targets , vol.17 , pp. 501-505
- Di Lorenzo, G.¹ Buonerba, C.² Gaudioso, G.³

16
- 41749108849
- PIK3CA, HRAS and KRAS gene mutations in human penile cancer
- Andersson P, Kolaric A, Windahl T,. PIK3CA, HRAS and KRAS gene mutations in human penile cancer. J Urol 2008; 179: 2030-2034
- (2008) J Urol , vol.179 , pp. 2030-2034
- Andersson, P.¹ Kolaric, A.² Windahl, T.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.